These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

404 related items for PubMed ID: 16678029

  • 1. Early renal benefit of rapamycin combined with reduced calcineurin inhibitor dose in pediatric heart transplantation patients.
    Balfour IC, Srun SW, Wood EG, Belsha CW, Marshall DL, Ferdman BR.
    J Heart Lung Transplant; 2006 May; 25(5):518-22. PubMed ID: 16678029
    [Abstract] [Full Text] [Related]

  • 2. First experience with rapamycin-based immunosuppression to improve kidney function after heart transplantation.
    Trösch F, Rothenburger M, Schneider M, Welp H, Etz C, Wilhelm MJ, Scheld HH, Schmid C.
    Thorac Cardiovasc Surg; 2004 Jun; 52(3):163-8. PubMed ID: 15192777
    [Abstract] [Full Text] [Related]

  • 3. Improvement in renal function and rejection control in pediatric liver transplant recipients with the introduction of sirolimus.
    Casas-Melley AT, Falkenstein KP, Flynn LM, Ziegler VL, Dunn SP.
    Pediatr Transplant; 2004 Aug; 8(4):362-6. PubMed ID: 15265163
    [Abstract] [Full Text] [Related]

  • 4. Improvement of renal function after the switch from a calcineurin inhibitor to everolimus in liver transplant recipients with chronic renal dysfunction.
    Castroagudín JF, Molina E, Romero R, Otero E, Tomé S, Varo E.
    Liver Transpl; 2009 Dec; 15(12):1792-7. PubMed ID: 19938140
    [Abstract] [Full Text] [Related]

  • 5. Renal function improves in liver transplant recipients when switched from a calcineurin inhibitor to sirolimus.
    Fairbanks KD, Eustace JA, Fine D, Thuluvath PJ.
    Liver Transpl; 2003 Oct; 9(10):1079-85. PubMed ID: 14526403
    [Abstract] [Full Text] [Related]

  • 6. Sirolimus in liver transplant recipients with renal dysfunction offers no advantage over low-dose calcineurin inhibitor regimens.
    DuBay D, Smith RJ, Qiu KG, Levy GA, Lilly L, Therapondos G.
    Liver Transpl; 2008 May; 14(5):651-9. PubMed ID: 18433069
    [Abstract] [Full Text] [Related]

  • 7. mTOR inhibitors: do they help preserve renal function?
    Moro J, Almenar L, Martínez-Dolz L, Agüero J, Rueda J, Arnau MA, Izquierdo M, Cano O, Sánchez-Lázaro I, Salvador A.
    Transplant Proc; 2007 Sep; 39(7):2135-7. PubMed ID: 17889116
    [Abstract] [Full Text] [Related]

  • 8. Renal function in renal or liver transplant recipients after conversion from a calcineurin inhibitor to sirolimus.
    Bäckman L, Reisaeter AV, Wramner L, Ericzon BG, Salmela K, Brattström C.
    Clin Transplant; 2006 Sep; 20(3):336-9. PubMed ID: 16824151
    [Abstract] [Full Text] [Related]

  • 9. Conversion from calcineurin inhibitor to sirolimus in pediatric chronic allograft nephropathy.
    Falger JC, Mueller T, Arbeiter K, Boehm M, Regele H, Balzar E, Aufricht C.
    Pediatr Transplant; 2006 Jun; 10(4):474-8. PubMed ID: 16712606
    [Abstract] [Full Text] [Related]

  • 10. Increase of proteinuria after conversion from calcineurin inhibitor to sirolimus-based treatment in kidney transplant patients with chronic allograft dysfunction.
    Ruiz JC, Campistol JM, Sánchez-Fructuoso A, Rivera C, Oliver J, Ramos D, Campos B, Arias M, Diekmann F.
    Nephrol Dial Transplant; 2006 Nov; 21(11):3252-7. PubMed ID: 16954170
    [Abstract] [Full Text] [Related]

  • 11. Everolimus with reduced calcineurin inhibitor in thoracic transplant recipients with renal dysfunction: a multicenter, randomized trial.
    Gullestad L, Iversen M, Mortensen SA, Eiskjaer H, Riise GC, Mared L, Bjørtuft O, Ekmehag B, Jansson K, Simonsen S, Gude E, Rundqvist B, Fagertun HE, Solbu D, Bergh CH.
    Transplantation; 2010 Apr 15; 89(7):864-72. PubMed ID: 20061999
    [Abstract] [Full Text] [Related]

  • 12. Recovery of renal function in heart transplantation patients after conversion from a calcineurin inhibitor-based therapy to sirolimus.
    Ayub-Ferreira SM, Avila MS, Feitosa FS, Souza GE, Mangini S, Marcondes-Braga FG, Issa VS, Bacal F, Chizzola PR, Cruz FD, Bocchi EA.
    Transplant Proc; 2010 Mar 15; 42(2):542-4. PubMed ID: 20304188
    [Abstract] [Full Text] [Related]

  • 13. Sirolimus as primary immunosuppressant for calcineurin inhibitor-related renal insufficiency after liver transplantation.
    Yang YJ, Li LX, He Q, Fan H, Jin ZK, Lang R, Kou JT, Li P, Xie DH, Chen DZ.
    Hepatobiliary Pancreat Dis Int; 2007 Aug 15; 6(4):376-8. PubMed ID: 17690032
    [Abstract] [Full Text] [Related]

  • 14. Sirolimus monotherapy in nephrotoxicity due to calcineurin inhibitors in liver transplant recipients.
    Nair S, Eason J, Loss G.
    Liver Transpl; 2003 Feb 15; 9(2):126-9. PubMed ID: 12548505
    [Abstract] [Full Text] [Related]

  • 15. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
    Yu S, He X, Yang L, Ma Y, Zhu X, Ju W, Huang J.
    Exp Clin Transplant; 2008 Jun 15; 6(2):113-7. PubMed ID: 18816237
    [Abstract] [Full Text] [Related]

  • 16. Improvement of renal dysfunction by conversion from calcineurin inhibitors to sirolimus after heart transplantation.
    Hunt J, Lerman M, Magee MJ, Dewey TM, Herbert M, Mack MJ.
    J Heart Lung Transplant; 2005 Nov 15; 24(11):1863-7. PubMed ID: 16297793
    [Abstract] [Full Text] [Related]

  • 17. Usefulness of sirolimus as rescue therapy in heart transplant recipients with renal failure: analysis of the Spanish Multicenter Observational Study (RAPACOR).
    Delgado JF, Crespo MG, Manito N, Camprecios M, Rábago G, Lage E, Arizón JM, Roig E.
    Transplant Proc; 2009 Nov 15; 41(9):3835-7. PubMed ID: 19917397
    [Abstract] [Full Text] [Related]

  • 18. [Sirolimus use in heart transplantation recipients with chronic renal dysfunction].
    Yin D, Huang J, Feng L, Liao ZK, Feng GX, Wang W, Song YH, Hu SS.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Feb 15; 40(2):136-40. PubMed ID: 22490714
    [Abstract] [Full Text] [Related]

  • 19. Sirolimus-based immunosuppression after cardiac transplantation: predictors of recovery from calcineurin inhibitor-induced renal dysfunction.
    Gustafsson F, Ross HJ, Delgado MS, Bernabeo G, Delgado DH.
    J Heart Lung Transplant; 2007 Oct 15; 26(10):998-1003. PubMed ID: 17919619
    [Abstract] [Full Text] [Related]

  • 20. Sirolimus monotherapy effectiveness in liver transplant recipients with renal dysfunction due to calcineurin inhibitors.
    Di Benedetto F, Di Sandro S, De Ruvo N, Spaggiari M, Montalti R, Ballarin R, Cappelli G, Gerunda GE.
    J Clin Gastroenterol; 2009 Mar 15; 43(3):280-6. PubMed ID: 19057397
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.